Imaging of Complications and Toxicity Following Tumour Therapy: Pelvis and Genitourinary (Male)

Part of the Medical Radiology book series (MEDRAD)


This chapter discusses the imaging of the complications and toxicity associated with treatment of the male genitourinary tract with particular focus on the imaging features which should alert the radiologist to the unwanted consequences of treatments, as well as imaging characteristics that may mimic or obscure any underlying disease.


Radical Prostatectomy External Beam Radiation Therapy Androgen Deprivation Therapy Urethral Stricture Pelvic Lymph Node Dissection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



The authors gratefully acknowledge the support of the NIHR Biomedical Research Centre for Cancer at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, UK.


  1. Abou Youssif T, Kassouf W et al (2007) Active surveillance for selected patients with renal masses: updated results with long-term follow-up. Cancer 110(5):1010–1014CrossRefPubMedGoogle Scholar
  2. Addley HC, Vargas HA et al (2010) Pelvic imaging following chemotherapy and radiation therapy for gynecologic malignancies. Radiographics Rev Publ Radiol Soc North Am Inc 30(7):1843–1856Google Scholar
  3. Ahmed HU, Freeman A et al (2011) Focal therapy for localized prostate cancer: a phase I/II trial. J Urol 185(4):1246–1254CrossRefPubMedGoogle Scholar
  4. Alemozaffar M, Regan MM et al (2011) Prediction of erectile function following treatment for prostate cancer. JAMA 306(11):1205–1214CrossRefPubMedGoogle Scholar
  5. Allen SD, Thompson A et al (2008) The normal post-surgical anatomy of the male pelvis following radical prostatectomy as assessed by magnetic resonance imaging. Eur Radiol 18(6):1281–1291CrossRefPubMedGoogle Scholar
  6. Atwell TD, Callstrom MR et al (2010) Percutaneous renal cryoablation: local control at mean 26 months of followup. J Urol 184(4):1291–1295CrossRefPubMedGoogle Scholar
  7. Aus G (2006) Current status of HIFU and cryotherapy in prostate cancer – a review. Eur Urol 50(5):927–934; discussion 934CrossRefPubMedGoogle Scholar
  8. Barchetti F, Panebianco V (2014) Multiparametric MRI for recurrent prostate cancer post radical prostatectomy and postradiation therapy. BioMed Res Int 2014:316272PubMedCentralPubMedGoogle Scholar
  9. Barnholtz-Sloan JS, Maldonado JL et al (2007) Incidence trends in primary malignant penile cancer. Urol Oncol 25(5):361–367CrossRefPubMedGoogle Scholar
  10. Baxter NN, Tepper JE et al (2005) Increased risk of rectal cancer after prostate radiation: a population-based study. Gastroenterology 128(4):819–824CrossRefPubMedGoogle Scholar
  11. Blake SP, Connors AM (2004) Sacral insufficiency fracture. Br J Radiol 77(922):891–896CrossRefPubMedGoogle Scholar
  12. Bloch S, Love A et al (2007) Psychological adjustment of men with prostate cancer: a review of the literature. BioPsychoSocial Med 1:2CrossRefGoogle Scholar
  13. Blomlie V, Rofstad EK et al (1996) Incidence of radiation-induced insufficiency fractures of the female pelvis: evaluation with MR imaging. AJR Am J Roentgenol 167(5):1205–1210CrossRefPubMedGoogle Scholar
  14. Brenner DJ, Curtis RE et al (2000) Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer 88(2):398–406CrossRefPubMedGoogle Scholar
  15. Campbell SC, Novick AC et al (2009) Guideline for management of the clinical T1 renal mass. J Urol 182(4):1271–1279CrossRefPubMedGoogle Scholar
  16. Chrouser K, Leibovich B et al (2005) Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer. J Urol 174(1):107–110; discussion 110–101CrossRefPubMedGoogle Scholar
  17. Cronin CG, Lohan DG et al (2010) Does MRI with oral contrast medium allow single-study depiction of inflammatory bowel disease enteritis and colitis? Eur Radiol 20(7):1667–1674CrossRefPubMedGoogle Scholar
  18. Crook J, McLean M et al (2002) Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation. Int J Radiat Oncol Biol Phys 52(2):453–460CrossRefPubMedGoogle Scholar
  19. Crook J, Ma C et al (2009) Radiation therapy in the management of the primary penile tumor: an update. World J Urol 27(2):189–196CrossRefPubMedGoogle Scholar
  20. Daniell HW, Dunn SR et al (2000) Progressive osteoporosis during androgen deprivation therapy for prostate cancer. J Urol 163(1):181–186CrossRefPubMedGoogle Scholar
  21. Dearnaley DP, Khoo VS et al (1999) Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet 353(9149):267–272CrossRefPubMedGoogle Scholar
  22. Delannes M, Malavaud B et al (1992) Iridium-192 interstitial therapy for squamous cell carcinoma of the penis. Int J Radiat Oncol Biol Phys 24(3):479–483CrossRefPubMedGoogle Scholar
  23. Diamond TH, Higano CS et al (2004) Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: recommendations for diagnosis and therapies. Cancer 100(5):892–899CrossRefPubMedGoogle Scholar
  24. Dickinson L, Ahmed HU et al (2013) A multi-centre prospective development study evaluating focal therapy using high intensity focused ultrasound for localised prostate cancer: The INDEX study. Contemp Clin Trials 36(1):68–80PubMedCentralCrossRefPubMedGoogle Scholar
  25. Dobson MJ, Carrington BM et al (2001) The assessment of irradiated bladder carcinoma using dynamic contrast-enhanced MR imaging. Clin Radiol 56(2):94–98CrossRefPubMedGoogle Scholar
  26. Emara AM, Chadwick E et al (2012) Long-term toxicity and quality of life up to 10 years after low-dose rate brachytherapy for prostate cancer. BJU Int 109(7):994–1000CrossRefPubMedGoogle Scholar
  27. Finiels H, Finiels PJ et al (1997) Fractures of the sacrum caused by bone insufficiency. Meta-analysis of 508 cases. Presse Med 26(33):1568–1573PubMedGoogle Scholar
  28. Finkelstein J, Eckersberger E et al (2010) Open versus laparoscopic versus robot-assisted laparoscopic prostatectomy: the European and US Experience. Rev Urol 12(1):35–43PubMedCentralPubMedGoogle Scholar
  29. Gangi A, Tsoumakidou G et al (2012) Percutaneous MR-guided cryoablation of prostate cancer: initial experience. Eur Radiol 22(8):1829–1835CrossRefPubMedGoogle Scholar
  30. Goldman SM, Fishman EK et al (1985) CT in the diagnosis of enterovesical fistulae. AJR Am J Roentgenol 144(6):1229–1233CrossRefPubMedGoogle Scholar
  31. Grangier C, Garcia J et al (1997) Role of MRI in the diagnosis of insufficiency fractures of the sacrum and acetabular roof. Skeletal Radiol 26(9):517–524CrossRefPubMedGoogle Scholar
  32. Grimm PD, Blasko JC et al (1996) Does brachytherapy have a role in the treatment of prostate cancer? Hematol Oncol Clin North Am 10(3):653–673CrossRefPubMedGoogle Scholar
  33. Grimm P, Billiet I et al (2012) Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group. BJU Int 109(Suppl 1):22–29CrossRefPubMedGoogle Scholar
  34. Hanks GE, Hanlon AL et al (2002) Dose response in prostate cancer with 8-12 years’ follow-up. Int J Radiat Oncol Biol Phys 54(2):427–435CrossRefPubMedGoogle Scholar
  35. Harris V, Benton B et al (2012) Bile acid malabsorption after pelvic and prostate intensity modulated radiation therapy: an uncommon but treatable condition. Int J Radiat Oncol Biol Phys 84(5):e601–e606CrossRefPubMedGoogle Scholar
  36. Heidenreich A, Varga Z et al (2002) Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol 167(4):1681–1686CrossRefPubMedGoogle Scholar
  37. Horton KM, Corl FM et al (2000) CT evaluation of the colon: inflammatory disease. Radiographics Rev Publ Radiol Soc North Am Inc 20(2):399–418Google Scholar
  38. Huber P, Debus J et al (1996) Therapeutic ultrasound in tumor therapy. Principles, applications and new developments. Radiologe 36(1):64–71CrossRefPubMedGoogle Scholar
  39. Hunter GK, Balagamwala EH et al (2012) The efficacy of external beam radiotherapy and stereotactic body radiotherapy for painful spinal metastases from renal cell carcinoma. Pract Radiat Oncol 2(4):e95–e100CrossRefPubMedGoogle Scholar
  40. Igdem S, Alco G et al (2010) Insufficiency fractures after pelvic radiotherapy in patients with prostate cancer. Int J Radiat Oncol Biol Phys 77(3):818–823CrossRefPubMedGoogle Scholar
  41. Jacob R, Hanlon AL et al (2004) The relationship of increasing radiotherapy dose to reduced distant metastases and mortality in men with prostate cancer. Cancer 100(3):538–543CrossRefPubMedGoogle Scholar
  42. Kapoor A, Touma NJ et al (2013) Review of the efficacy and safety of cryoablation for the treatment of small renal masses. Canad Urol Assoc J = Journal de l’Association des urologues du Canada 7(1-2):E38–E44Google Scholar
  43. Kawamoto S, Permpongkosol S et al (2007) Sequential changes after radiofrequency ablation and cryoablation of renal neoplasms: role of CT and MR imaging. Radiographics Rev Publ Radiol Soc North Am Inc 27(2):343–355Google Scholar
  44. Kayhan A, Oommen J et al (2010) Magnetic resonance enterography in Crohn’s disease: standard and advanced techniques. World J Radiol 2(4):113–121PubMedCentralCrossRefPubMedGoogle Scholar
  45. Kirkham AP, Emberton M et al (2008) MR imaging of prostate after treatment with high-intensity focused ultrasound. Radiology 246(3):833–844CrossRefPubMedGoogle Scholar
  46. Lang EK, Thomas R et al (2004) Multiphasic helical CT criteria for differentiation of recurrent neoplasm and desmoplastic reaction after laparoscopic resection of renal mass lesions. J Endourol/Endourol Soc 18(2):167–171CrossRefGoogle Scholar
  47. Lee MS, Oh YT et al (2007) CT findings after nephron-sparing surgery of renal tumors. AJR Am J Roentgenol 189(5):W264–W271CrossRefPubMedGoogle Scholar
  48. Locke J, Ellis W et al (2002) Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy: a prospective study. Int J Radiat Oncol Biol Phys 52(3):712–719CrossRefPubMedGoogle Scholar
  49. Michalski JM, Bae K et al (2010) Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study. Int J Radiat Oncol Biol Phys 76(1):14–22PubMedCentralCrossRefPubMedGoogle Scholar
  50. Nomura T, Mimata H (2012) Focal therapy in the management of prostate cancer: an emerging approach for localized prostate cancer. Advance Urol 2012:391437Google Scholar
  51. Oh D, Huh SJ et al (2008) Pelvic insufficiency fracture after pelvic radiotherapy for cervical cancer: analysis of risk factors. Int J Radiat Oncol Biol Phys 70(4):1183–1188CrossRefPubMedGoogle Scholar
  52. Ohri N, Dicker AP et al (2012) Late toxicity rates following definitive radiotherapy for prostate cancer. Can J Urol 19(4):6373–6380PubMedCentralPubMedGoogle Scholar
  53. Outwater E, Schiebler ML (1993) Pelvic fistulas: findings on MR images. AJR Am J Roentgenol 160(2):327–330CrossRefPubMedGoogle Scholar
  54. Pizzocaro G, Piva L et al (1997) Up-to-date management of carcinoma of the penis. Eur Urol 32(1):5–15PubMedGoogle Scholar
  55. Ravichandran S, Ahmed HU et al (2008) Is there a role for magnetic resonance imaging in diagnosing colovesical fistulas? Urology 72(4):832–837CrossRefPubMedGoogle Scholar
  56. Reed DR, Wallner KE et al (2007) A prospective randomized comparison of stranded vs. loose 125I seeds for prostate brachytherapy. Brachytherapy 6(2):129–134CrossRefPubMedGoogle Scholar
  57. Roach M 3rd, DeSilvio M et al (2003) Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413. J Clin Oncol: Off J Am Soc Clin Oncol 21(10):1904–1911CrossRefGoogle Scholar
  58. Sarwani NI, Motta Ramirez GA et al (2007) Imaging findings after minimally invasive nephron-sparing renal therapies. Clin Radiol 62(4):333–339CrossRefPubMedGoogle Scholar
  59. Schneider R, Yacovone J et al (1985) Unsuspected sacral fractures: detection by radionuclide bone scanning. AJR Am J Roentgenol 144(2):337–341CrossRefPubMedGoogle Scholar
  60. Shahinian VB, Kuo YF et al (2005) Risk of fracture after androgen deprivation for prostate cancer. N Engl J Med 352(2):154–164CrossRefPubMedGoogle Scholar
  61. Singh AK, Saokar A et al (2005) Imaging of penile neoplasms. Radiographics Rev Publ Radiol Soc North Am Inc 25(6):1629–1638Google Scholar
  62. Smith MR, Boyce SP et al (2006) Risk of clinical fractures after gonadotropin-releasing hormone agonist therapy for prostate cancer. J Urol 175(1):136–139; discussion 139CrossRefPubMedGoogle Scholar
  63. Sohaib SA, Cook G et al (2011) Imaging studies for germ cell tumors. Hematol Oncol Clin North Am 25(3):487–502, viiCrossRefPubMedGoogle Scholar
  64. Solberg A, Angelsen A et al (2003) Frequency of lymphoceles after open and laparoscopic pelvic lymph node dissection in patients with prostate cancer. Scand J Urol Nephrol 37(3):218–221CrossRefPubMedGoogle Scholar
  65. Stoker J (2010) MRI of the gastrointestinal tract. Springer, Berlin/HeidelbergCrossRefGoogle Scholar
  66. Stone NN, Stock RG (2007) Long-term urinary, sexual, and rectal morbidity in patients treated with iodine-125 prostate brachytherapy followed up for a minimum of 5 years. Urology 69(2):338–342CrossRefPubMedGoogle Scholar
  67. Sugimura K, Carrington BM et al (1990) Postirradiation changes in the pelvis: assessment with MR imaging. Radiology 175(3):805–813CrossRefPubMedGoogle Scholar
  68. Tang YZ, Booth TC et al (2012) Imaging features of colovesical fistulae on MRI. Br J Radiol 85(1018):1371–1375PubMedCentralCrossRefPubMedGoogle Scholar
  69. Thompson RH, Boorjian SA et al (2008) Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol 179(2):468–471; discussion 472–63CrossRefPubMedGoogle Scholar
  70. Travis LB, Fossa SD et al (2005) Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst 97(18):1354–1365CrossRefPubMedGoogle Scholar
  71. Trofimov A, Nguyen PL et al (2007) Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison. Int J Radiat Oncol Biol Phys 69(2):444–453PubMedCentralCrossRefPubMedGoogle Scholar
  72. Turini M, Redaelli A et al (2003) Quality of life and economic considerations in the management of prostate cancer. Pharmacoeconomics 21(8):527–541CrossRefPubMedGoogle Scholar
  73. Vallancien G, Prapotnich D et al (2004) Transrectal focused ultrasound combined with transurethral resection of the prostate for the treatment of localized prostate cancer: feasibility study. J Urol 171(6 Pt 1):2265–2267CrossRefPubMedGoogle Scholar
  74. Vargas C, Fryer A et al (2008) Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 70(3):744–751CrossRefPubMedGoogle Scholar
  75. Venkatesan AM, Wood BJ et al (2011) Percutaneous ablation in the kidney. Radiology 261(2):375–391PubMedCentralCrossRefPubMedGoogle Scholar
  76. Wah TM, Arellano RS et al (2005) Image-guided percutaneous radiofrequency ablation and incidence of post-radiofrequency ablation syndrome: prospective survey. Radiology 237(3):1097–1102CrossRefPubMedGoogle Scholar
  77. Ward JF, Jones JS (2012) Focal cryotherapy for localized prostate cancer: a report from the national Cryo On-Line Database (COLD) Registry. BJU Int 109(11):1648–1654CrossRefPubMedGoogle Scholar
  78. Weight CJ, Reuther AM et al (2008) Limited pelvic lymph node dissection does not improve biochemical relapse-free survival at 10 years after radical prostatectomy in patients with low-risk prostate cancer. Urology 71(1):141–145CrossRefPubMedGoogle Scholar
  79. Wile GE, Leyendecker JR et al (2007) CT and MR imaging after imaging-guided thermal ablation of renal neoplasms. Radiographics Rev Publ Radiol Soc North Am Inc 27(2):325–339; discussion 339–40Google Scholar
  80. Wilt TJ, MacDonald R et al (2008) Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med 148(6):435–448CrossRefPubMedGoogle Scholar
  81. Woodrum DA, Kawashima A et al (2013) Magnetic resonance imaging-guided cryoablation of recurrent prostate cancer after radical prostatectomy: initial single institution experience. Urology 82(4):870–875CrossRefPubMedGoogle Scholar
  82. Zagoria RJ (2004) Imaging-guided radiofrequency ablation of renal masses. Radiographics Rev Publ Radiol Soc Am Inc 24(Suppl 1):S59–S71Google Scholar
  83. Zelefsky MJ, Hollister T et al (2000) Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer. Int J Radiat Oncol Biol Phys 47(5):1261–1266CrossRefPubMedGoogle Scholar
  84. Zelefsky MJ, Greco C et al (2012) Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma. Int J Radiat Oncol Biol Phys 82(5):1744–1748PubMedCentralCrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  1. 1.Department of Diagnostic RadiologyRoyal Marsden HospitalSutton, SurreyUK
  2. 2.Department of Diagnostic RadiologyRoyal Marsden NHS Foundation TrustSutton, SurreyEngland, UK

Personalised recommendations